Developing Conjugate Vaccines

A conjugate vaccine is created by covalently attaching a poor (polysaccharide) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes of the carrier to the attached antigen.

Vaccines: Following the great success of the 5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, July 27-28, 2015 Brisbane, AustraliaOMICS Group International is organizing the 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination which is going to be held in Melbourne, Australia in 2016. This will be the latest in the OMICS group annual vaccine meeting series with 500 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research.

Related Conferences: Children Vaccines 2016 Oct 10-12, 2016 Rome, Italy; International Conference on H1N1 & Influenza Vaccines July 25-26, 2016 Chicago, USA; International Conference on Hepatitis Vaccines Conference June 16-18, 2016 Rome, Italy; Annual Conference on Virulent Hiv Vaccines Conference Oct 3-5, 2016 Miami, USA; 10th Euro Global Summit and Expo on Vaccines & Vaccination 16-18, 2016 Rome, Italy; 13th Vaccines Asia Pacific Global summit and Expo on Vaccines & Vaccination Conference November 03-05, 2016 Melbourne, Australia;  Conjugated Immunogenics Valencia Spain;  8th Annual Cancer Drugs Research Development California, United States;  Conference on Vaccine Research Innovation London, United Kingdom;  Conference on Vaccine Research and Development London, United Kingdom;  Second International China BioPharmaceutical Symposium, ICBPS-2 Beijing, China;  Antibody Discovery Pre-Clinical Drug Development California, United States

A conjugate vaccine is created by covalently attaching a poor (polysaccharide) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes of the carrier to the attached antigen.

Vaccines: Following the great success of the 5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, July 27-28, 2015 Brisbane, AustraliaOMICS Group International is organizing the 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination which is going to be held in Melbourne, Australia in 2016. This will be the latest in the OMICS group annual vaccine meeting series with 500 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research.

Related Conferences: Children Vaccines 2016 Oct 10-12, 2016 Rome, Italy; International Conference on H1N1 & Influenza Vaccines July 25-26, 2016 Chicago, USA; International Conference on Hepatitis Vaccines Conference June 16-18, 2016 Rome, Italy; Annual Conference on Virulent Hiv Vaccines Conference Oct 3-5, 2016 Miami, USA; 10th Euro Global Summit and Expo on Vaccines & Vaccination 16-18, 2016 Rome, Italy; 13th Vaccines Asia Pacific Global summit and Expo on Vaccines & Vaccination Conference November 03-05, 2016 Melbourne, Australia;  Conjugated Immunogenics Valencia Spain;  8th Annual Cancer Drugs Research Development California, United States;  Conference on Vaccine Research Innovation London, United Kingdom;  Conference on Vaccine Research and Development London, United Kingdom;  Second International China BioPharmaceutical Symposium, ICBPS-2 Beijing, China;  Antibody Discovery Pre-Clinical Drug Development California, United States

  • New approaches to combat bacterial pathogens
  • Public health concerns in vaccination
  • Contraindications - Vaccines, vaccination
  • Others
  • Vaccines formulation and technologies used in conjugated vaccines

Developing Conjugate Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in